cytarabine has been researched along with Day Blindness in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, A; Patnaik, MM; Viswanatha, DS | 1 |
| Huang, TS; Lin, HW; Shih, SR; Yao, M | 1 |
| Krema, H; Pavlin, CJ; Santiago, RA; Schuh, A | 1 |
| Berger, F; Cimarelli, S; Formaglio, M; Ghesquières, H; Lachenal, F | 1 |
| Bron, AJ; Lochhead, J; Salmon, JF | 1 |
| Barada, WM; Bazarbachi, A; Beydoun, A; Hourani, R; Masroujeh, R; Otrock, ZK | 1 |
| Alster, Y; Ben-Tal, O; Lowenstein, A; Schwartz, J | 1 |
| Appen, RE; Roth, H; Varakis, JN; ZuRhein, GM | 1 |
1 review(s) available for cytarabine and Day Blindness
| Article | Year |
|---|---|
Relapse of acute myeloid leukemia at the pituitary gland: a case report and review of literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Diabetes Insipidus; Etoposide; Female; Humans; Hypopituitarism; Idarubicin; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Methotrexate; Pituitary Neoplasms; Radiotherapy; Recurrence; Remission Induction; Vision Disorders | 2012 |
7 other study(ies) available for cytarabine and Day Blindness
| Article | Year |
|---|---|
FLT3 Mutation Testing in Acute Myeloid Leukemia.
Topics: Cytarabine; Daunorubicin; fms-Like Tyrosine Kinase 3; Genetic Testing; Headache; Humans; Leukapheresis; Leukemia, Myeloid, Acute; Leukostasis; Male; Middle Aged; Segmental Duplications, Genomic; Tandem Repeat Sequences; Vision Disorders | 2017 |
Cytarabine toxicity of the corneal endothelium.
Topics: Adult; Antimetabolites, Antineoplastic; Cytarabine; Endothelium, Corneal; Eye Diseases; Humans; Leukemia, Myeloid, Acute; Male; Vision Disorders | 2013 |
Primary cerebral angioimmunoblastic T-cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Confusion; Cytarabine; Diagnosis, Differential; Female; Gene Rearrangement; Genes, T-Cell Receptor gamma; Humans; Immunoblastic Lymphadenopathy; Immunohistochemistry; Lymphoma, T-Cell; Magnetic Resonance Imaging; Methotrexate; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Vision Disorders | 2013 |
Cytarabine-induced corneal toxicity.
Topics: Acute Disease; Adult; Antimetabolites, Antineoplastic; Corneal Diseases; Cytarabine; Humans; Leukemia, Myeloid; Male; Vision Disorders | 2003 |
Transient global amnesia associated with the infusion of DMSO-cryopreserved autologous peripheral blood stem cells.
Topics: Adult; Alkalosis, Respiratory; Amnesia, Retrograde; Amnesia, Transient Global; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Combined Modality Therapy; Confusion; Cryoprotective Agents; Cytarabine; Dacarbazine; Dexamethasone; Dimethyl Sulfoxide; Doxorubicin; Etoposide; Hippocampus; Hodgkin Disease; Humans; Hyperventilation; Ifosfamide; Magnetic Resonance Imaging; Male; Melphalan; Paresthesia; Peripheral Blood Stem Cell Transplantation; Salvage Therapy; Vinblastine; Vision Disorders | 2008 |
Visual loss following high-dose cytosine arabinoside (ARA-C)
Topics: Adult; Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Nervous System Diseases; Vision Disorders | 2000 |
Progressive multifocal leukoencephalopathy. A cause of visual loss.
Topics: Cytarabine; Humans; Leukoencephalopathy, Progressive Multifocal; Male; Middle Aged; Occipital Lobe; Papillomaviridae; Polyomaviridae; Temporal Lobe; Virus Diseases; Vision Disorders; Visual Fields | 1977 |